CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma

Cancer statistics, 2012

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text

Widespread microRNA repression by Myc contributes to tumorigenesis

Tsung-Cheng Chang, Duonan Yu, Yun‐Sil Lee et al. · Nature Genetics · 2007 · 1.3K citations · Full text

Widespread Microrna Repression, Small Rna, Microrna Detection +5

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

Li Ma, Jennifer J. Young, Harsha Prabhala et al. · Nature Cell Biology · 2010 · 1.3K citations · Full text

Tumor Biology, Medicine, Myc/mycn-activated Microrna +5

Modelling Myc inhibition as a cancer therapy

Laura Soucek, Jonathan R. Whitfield, Carla P. Martins et al. · Nature · 2008 · 805 citations · Full text

Myc Inhibition, Tumor Biology, Oncology +6

Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium

Shahrokh F. Shariat, Pierre I. Karakiewicz, Ganesh S. Palapattu et al. · The Journal of Urology · 2006 · 696 citations